Janney Montgomery Scott Downgrades Clovis Oncology (CLVS) to Neutral

September 21, 2016 11:19 AM EDT
Get Alerts CLVS Hot Sheet
Price: $29.24 -5.28%

Rating Summary:
    4 Buy, 7 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 30 | Down: 45 | New: 20
Trade CLVS Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Janney Montgomery Scott downgraded Clovis Oncology (NASDAQ: CLVS) from Buy to Neutral with a price target of $36.00 (from $30.00).

For an analyst ratings summary and ratings history on Clovis Oncology click here. For more ratings news on Clovis Oncology click here.

Shares of Clovis Oncology closed at $34.83 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change, Downgrades, Hot Downgrades, Momentum Movers

Related Entities

Janney Montgomery Scott

Add Your Comment